These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 32865715)

  • 1. Proposal for a post-operative surveillance strategy for stage I colorectal cancer patients based on a novel recurrence risk stratification: a multicenter retrospective study.
    Ozawa T; Hashiguchi Y; Ishihara S; Hayama T; Tsuchiya T; Nozawa K; Yamauchi S; Sugihara K; Matsuda K
    Int J Colorectal Dis; 2021 Jan; 36(1):67-74. PubMed ID: 32865715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of carcinoembryonic antigen and carbohydrate antigen 19-9 in stage IV colorectal cancer patients after R0 resection.
    Abe S; Kawai K; Ishihara S; Nozawa H; Hata K; Kiyomatsu T; Tanaka T; Watanabe T
    J Surg Res; 2016 Oct; 205(2):384-392. PubMed ID: 27664887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prognostic mutation panel for predicting cancer recurrence in stages II and III colorectal cancer.
    Sho S; Court CM; Winograd P; Russell MM; Tomlinson JS
    J Surg Oncol; 2017 Dec; 116(8):996-1004. PubMed ID: 28767131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for recurrence in stage II/III colorectal cancer patients treated with curative surgery: The impact of postoperative tumor markers and an infiltrative growth pattern.
    Tokodai K; Narimatsu H; Nishida A; Takaya K; Hara Y; Kawagishi N; Hashizume E; Ohuchi N
    J Surg Oncol; 2016 Sep; 114(3):368-74. PubMed ID: 27264681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Recurrence-Predictive Indicators in Stage I Colorectal Cancer.
    Lee JH; Lee JL; Park IJ; Lim SB; Yu CS; Kim JC
    World J Surg; 2017 Apr; 41(4):1126-1133. PubMed ID: 27872975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive Nomogram for Recurrence of Stage I Colorectal Cancer After Curative Resection.
    Kim C; Kim WR; Kim KY; Chon HJ; Beom SH; Kim H; Jung M; Shin SJ; Kim NK; Ahn JB
    Clin Colorectal Cancer; 2018 Sep; 17(3):e513-e518. PubMed ID: 29661621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for recurrence in elderly patients with stage II colorectal cancer: a multicenter retrospective study.
    Yagyu T; Yamamoto M; Tanio A; Hara K; Sugezawa K; Uejima C; Kihara K; Tatebe S; Kurisu Y; Shibata S; Yamamoto T; Nishie H; Shiota S; Saito H; Naka T; Sugamura K; Katano K; Fujiwara Y
    BMC Cancer; 2022 Apr; 22(1):390. PubMed ID: 35410196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal Surveillance Protocols After Curative Resection in Patients With Stage IV Colorectal Cancer: A Multicenter Retrospective Study.
    Kishiki T; Lapin B; Matsuoka H; Watanabe T; Takayasu K; Kojima K; Sugihara K; Masaki T
    Dis Colon Rectum; 2018 Jan; 61(1):51-57. PubMed ID: 29215480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive factors of early relapse in UICC stage I-III colorectal cancer patients after curative resection.
    Tsai HL; Chu KS; Huang YH; Su YC; Wu JY; Kuo CH; Chen CW; Wang JY
    J Surg Oncol; 2009 Dec; 100(8):736-43. PubMed ID: 19757443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Predictive value of combination detection of tissue Pgp1 expression and preoperative serum CEA level for colorectal cancer].
    Wu F; Chen L; Wu W; Jiang B; Su X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):443-449. PubMed ID: 28440527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-operative aspirin use and colorectal cancer-specific survival in patients with stage I-III colorectal cancer.
    Goh CH; Leong WQ; Chew MH; Pan YS; Tony LK; Chew L; Tan IB; Toh HC; Tang CL; Fu WP; Chia WK
    Anticancer Res; 2014 Dec; 34(12):7407-14. PubMed ID: 25503181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term Recurrence-free Survival After Standard Endoscopic Resection Versus Surgical Resection of Submucosal Invasive Colorectal Cancer: A Population-based Study.
    Belderbos TD; van Erning FN; de Hingh IH; van Oijen MG; Lemmens VE; Siersema PD
    Clin Gastroenterol Hepatol; 2017 Mar; 15(3):403-411.e1. PubMed ID: 27609703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A high preoperative carbohydrate antigen 19-9 level is a risk factor for recurrence in stage II colorectal cancer.
    Nozawa H; Ishihara S; Kawai K; Hata K; Kiyomatsu T; Tanaka T; Nishikawa T; Otani K; Yasuda K; Sasaki K; Murono K; Watanabe T
    Acta Oncol; 2017 May; 56(5):634-638. PubMed ID: 27885879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of high-risk stage I colon and rectal cancer patients: a retrospective analysis of a large Japanese cohort.
    Fukui Y; Hida K; Hoshino N; Nishizaki D; Okamura R; Yamauchi S; Sugihara K; Sakai Y;
    Int J Colorectal Dis; 2022 Jun; 37(6):1403-1410. PubMed ID: 35588331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of postoperative inflammation on recurrence in patients with colorectal cancer.
    Matsubara D; Arita T; Nakanishi M; Kuriu Y; Murayama Y; Kudou M; Konishi H; Komatsu S; Shiozaki A; Otsuji E
    Int J Clin Oncol; 2020 Apr; 25(4):602-613. PubMed ID: 31758273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Outcome and Prognostic Factors of Sporadic Colorectal Cancer in Young Patients: A Large Institutional-Based Retrospective Study.
    Kim TJ; Kim ER; Hong SN; Chang DK; Kim YH
    Medicine (Baltimore); 2016 May; 95(19):e3641. PubMed ID: 27175682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sarcopenia is a Negative Prognostic Factor After Curative Resection of Colorectal Cancer.
    Miyamoto Y; Baba Y; Sakamoto Y; Ohuchi M; Tokunaga R; Kurashige J; Hiyoshi Y; Iwagami S; Yoshida N; Yoshida M; Watanabe M; Baba H
    Ann Surg Oncol; 2015 Aug; 22(8):2663-8. PubMed ID: 25564158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative serum carcinoembryonic antigen, carbohydrate antigen19-9 and carbohydrate antigen 125 as prognostic factors for recurrence-free survival in colorectal cancer.
    Yang XQ; Chen C; Wang FB; Peng CW; Li Y
    Asian Pac J Cancer Prev; 2011; 12(5):1251-6. PubMed ID: 21875276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Impact of Histologic Type in Curatively Resected Stage IV Colorectal Cancer: A Japanese Multicenter Retrospective Study.
    Shibata J; Kawai K; Nishikawa T; Tanaka T; Tanaka J; Kiyomatsu T; Hata K; Nozawa H; Kazama S; Yamaguchi H; Ishihara S; Sunami E; Kitayama J; Sugihara K; Watanabe T
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S621-9. PubMed ID: 26350364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic parameters associated with postoperative complications and risk factors for tumor recurrence and mortality after tumor resection of patients with colorectal cancer.
    Bai Z; Wang J; Wang T; Li Y; Zhao X; Wu G; Yang Y; Deng W; Zhang Z
    Clin Transl Oncol; 2018 Feb; 20(2):176-192. PubMed ID: 28710725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.